Cargando…
Osteomalacia as a Late Metabolic Complication of Ifosfamide Chemotherapy in Young Adults: Illustrative Cases and Review of the Literature
Purpose. Ifosfamide is a drug commonly used in the management of sarcomas and other solid tumours. One potential toxicity of its use is renal tubular damage, which can lead to skeletal abnormalities; rickets in children and osteomalacia in adults. We aimed to characterise this rare complication in a...
Autores principales: | Church, D. N., Hassan, A. B., Harper, S. J., Wakeley, C. J., Price, C. G. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906873/ https://www.ncbi.nlm.nih.gov/pubmed/17641745 http://dx.doi.org/10.1155/2007/91586 |
Ejemplares similares
-
Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females
por: Zanetta, G, et al.
Publicado: (1999) -
Hypophosphatemic Osteomalacia in a Young Adult
por: Paramba, Firjeeth, et al.
Publicado: (2021) -
Systemic complications of the bidirectional intraoperative chemotherapy with intravenous ifosfamide and hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin
por: Hakeam, Hakeam, et al.
Publicado: (2019) -
The Distribution and Treatment of Late Rickets and Osteomalacia in Northern India
por: Wilson, Dagmar Curjel
Publicado: (1931) -
Oncogenic osteomalacia illustrating the effect of fibroblast growth factor 23 on phosphate homeostasis
por: Westerberg, Per-Anton, et al.
Publicado: (2012)